GL Ventures leads $92m Series D in Chinese molecular diagnostics specialist Coyote

GL Ventures leads $92m Series D in Chinese molecular diagnostics specialist Coyote

Coyote Bioscience. Visuals from the company website

23 December, 2020

COVID-19 Coyote Bioscience GL Ventures Hillhouse Capital

Printed by Unregistered user on Sun, 14 Dec 2025 18:35:59 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

COVID-19 gives rise to M&A opportunities for SE Asian firms amid crisis

Venture Capital

GL Ventures, LAV co-lead $50m Series A funding in vision therapy firm Elumninex

Read more from Greater China

China Vanke’s bond payment extension rejected, raising default risk

Editor’s Take: The Week That Was—Dec 8-13